InvestorsHub Logo
Followers 7
Posts 117
Boards Moderated 0
Alias Born 02/16/2020

Re: None

Monday, 06/22/2020 9:41:03 PM

Monday, June 22, 2020 9:41:03 PM

Post# of 426182
Boehringer Ingelheim a major shareholder in Hikma Pharmaceuticals is exiting the London listed drugmaker by selling most of its nearly one billion pound stake to institutional investors and the rest back to the company Hikma.


I found this interesting.

https://www.boehringer-ingelheim.com/metabolic-diseases/diabetes/podcast-series?itid=It%E2%80%99s%20Your%20Heart.%20Protect%20It.%20The%20Podcast
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News